S&T Bank Arrowhead Pharmaceuticals, Inc. Transaction History
S&T Bank
- $309 Million
- Q2 2025
A detailed history of S&T Bank transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, S&T Bank holds 686 shares of ARWR stock, worth $12,210. This represents 0.0% of its overall portfolio holdings.
Number of Shares
686
Previous 686
-0.0%
Holding current value
$12,210
Previous $8,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ARWR
# of Institutions
302Shares Held
100MCall Options Held
306KPut Options Held
432K-
Black Rock Inc. New York, NY15.7MShares$279 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$276 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$198 Million2.29% of portfolio
-
State Street Corp Boston, MA7MShares$125 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$93.1 Million1.32% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.88B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...